In a challenging year for biotechnology firms, PureTech Health PLC (PRTC) stock has touched a 52-week low, dipping to $16.81.

Insights and expert perspectives focused on the convergence of risk and resilience for secure network operations and business ...

Report on how AI is redefining market landscape - The global microbiomes market size is estimated to grow by USD 1.13 billion from 2024-2028, according to Technavio. The market is estimated to grow at ...

While it looks like a camouflaged version of the current DS 4, this mid-life refresh is set to introduce a new No4 name to DS ...

LYT-200 now has gained fast track designation from the FDA in acute myeloid leukemia in addition to its prior designation for ...

Peugeot Malaysia has announced a special rebate of RM21,500 for the Peugeot 2008, bringing the striking B-segment SUV’s price ...

Looking for a stylish and affordable crossover? The Peugeot 2008 is now available with a special RM21,500 rebate, plus a ...

Peugeot Malaysia announced a special rebate of RM 21,500 off the Peugeot 2008. With the discounts added in, the French rival ...

Request To Download Free Sample of This Strategic Report @ The report provides in-depth analysis and insights regarding the current global market scenario, latest trends and drivers into global CAR T ...

https://www.tipranks.com/news/the-fly/trulieve-cannabis-price-target-lowered-to-c19-from-c23-at-alliance-global-partners PureTech Health (PRTC) announced that the U.S ...

“Fast Track designation from the FDA reinforces our belief in the potential for LYT-200 to address the urgent needs of AML patients,” said Luba Greenwood, J.D., Entrepreneur-in-Residence at PureTech ...

PureTech Health plc, engages in the development and commercialization of biotechnology and pharmaceutical solutions in the United States. The company is developing LYT-100, which is under Phase 2 ...